MedPath

Percutaneous Electrolysis Versus Dry Needling in Levator Scapulae

Not Applicable
Completed
Conditions
Myofascial Pain
Trigger Point Pain, Myofascial
Registration Number
NCT04157426
Lead Sponsor
Universidad Complutense de Madrid
Brief Summary

The objective will be to determine the effectiveness of ultrasound-guided percutaneous electrolysis versus ultrasound-guided dry needling in active myofascial trigger points of the levator scapulae muscle on pain intensity, disability and range of motion. A randomized clinical trial will be carried out. Fifty-four patients with at least one active myofascial trigger point in the levator scapulae muscle were recruited and divided into ultrasound-guided percutaneous electrolysis (n = 27) and ultrasound-guided dry needling (n=27). Pain intensity, disability and range of motion will measured before, immediately after and 1 week after intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Neck pain
  • At least two active myofascial trigger point in the levator scapulae muscle
Exclusion Criteria
  • Systemic diseases
  • Cognitive impairment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain intensityChange from baseline pain intensity immediately and at 1 week after intervention

Neck pain intensity scores from 0 to 100 points measured by the visual analogue scale

Secondary Outcome Measures
NameTimeMethod
Range of motionChange from baseline pain intensity immediately and at 1 week after intervention

Neck rotation range of motion measured with an universal goniometer

DisabilityChange from baseline pain intensity at 1 week after intervention

Neck disability scores measured from 0 to 50 points measured by the Neck Disability Index

Trial Locations

Locations (1)

Fisiofuenla SLP

🇪🇸

Fuenlabrada, Madrid, Spain

Fisiofuenla SLP
🇪🇸Fuenlabrada, Madrid, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.